Incruse Ellipta

Incruse Ellipta belongs to GSK plc through GlaxoSmithKline LLC. Incruse Ellipta is owned by GSK plc, headquartered in the United Kingdom. No. The ultimate owner of Incruse Ellipta, GSK plc, is headquartered in the United Kingdom, not in the United States.

GSK is a global healthcare company that researches, develops, and manufactures innovative medicines, vaccines, and consumer healthcare products.